U.S. Clinical Trial Begins for a Cannabis-Based Pain Medication
Don’t miss important updates about Ohio’s marijuana program. Subscribe to our newsletter and get the latest straight to your email!
A new clinical trial in the United States is bringing attention to the potential role of marijuana in pain management. Researchers in New York are studying a cannabis-based medication designed to help people with chronic lower back pain, particularly those who have not found enough relief from opioid-based treatments.
The medication, known as VER-01, contains several cannabinoids, including THC, CBD, and CBG. It has already been studied in Europe, where clinical trial results showed promising findings for pain reduction. Now, researchers are investigating its safety and effectiveness in American patients.
This research could help expand our understanding of how marijuana-based treatments may fit into modern pain management.
What Is VER-01?
VER-01 is an investigational pain medication developed by the German pharmaceutical company Vertanical. It is made from a standardized marijuana extract, meaning its cannabinoid content is carefully controlled to provide consistent doses.
The medication contains three cannabinoids:
THC (tetrahydrocannabinol): THC is the primary psychoactive compound in marijuana. It interacts with the body's endocannabinoid system, which plays a role in pain perception.
CBD (cannabidiol): CBD is a non-intoxicating cannabinoid being studied for its potential effects on pain and inflammation.
CBG (cannabigerol): CBG is a less widely studied cannabinoid that researchers are continuing to investigate for its possible therapeutic properties.
Unlike the variety of marijuana products available at dispensaries, VER-01 is being developed with a standardized cannabinoid formulation and consistent dosing. This allows researchers to study specific amounts of THC, CBD, and CBG and evaluate their effects under controlled clinical conditions. Its standardized composition allows researchers to study consistent doses and their effects.
What Is the U.S. Clinical Trial Studying?
The clinical trial is taking place in western New York, with investigators at Upstate Clinical Research Associates in Williamsville overseeing the initial research.
The study focuses on people with chronic lower back pain who have not responded adequately to opioid-based treatments.
Researchers are using a placebo-controlled design, meaning some participants receive the investigational medication while others receive an inactive treatment. By comparing the two groups, researchers can determine whether changes in pain and other symptoms are actually related to VER-01 rather than other factors. This allows researchers to compare results and determine whether improvements are related to the medication.
The study will examine several factors, including:
How much VER-01 reduces chronic lower back pain
Whether it improves sleep and physical functioning
What side effects or safety concerns may occur
Whether it could offer another option for people who have not found enough relief from existing treatments
What Have Previous Studies Found?
VER-01 has already undergone clinical testing in Europe. Previous Phase 3 studies reported promising results for people with chronic lower back pain.
VER-01 has already undergone clinical testing in Europe, where two Phase 3 studies reported promising results for people with chronic lower back pain.
One study published in Nature Medicine involving 820 adults found that participants taking VER-01 experienced an average pain reduction of 1.9 points on an 11-point scale, compared with 1.4 points among those receiving a placebo.
Participants taking VER-01 also reported improvements in sleep, physical functioning, and quality of life.
Another Phase 3 study published in Pain and Therapy compared VER-01 with opioid medications in 384 adults. Researchers found that the VER-01 group experienced less constipation, a common opioid side effect, along with slightly greater average improvements in pain and sleep over six months.
Although these studies were conducted in Europe, their findings provide encouraging evidence of VER-01's potential as a treatment for chronic pain. The ongoing U.S. clinical trial will help researchers determine whether similar results can be achieved in American patients. It's another important step toward understanding how standardized marijuana-based medications may offer additional options for people living with persistent pain. However, these findings apply specifically to VER-01 and cannot automatically be applied to all marijuana products.
Why Is This Research Important for Chronic Pain Patients?
Chronic pain can interfere with sleep, physical activity, work, and everyday responsibilities. While traditional treatments such as physical therapy, anti-inflammatory medications, and prescription pain relievers help some people, others continue to experience symptoms or unwanted side effects.
This is one reason researchers are exploring marijuana-based treatments.
The body's endocannabinoid system helps regulate several functions, including pain perception, sleep, and inflammation. Cannabinoids such as THC and CBD interact with this system in different ways.
By studying specific cannabinoid combinations, researchers hope to better understand how these compounds affect pain and whether they can provide another treatment option.
Does VER-01 Have FDA Approval?
No. VER-01 is still an investigational medication and has not received FDA approval for general use. Although it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA), this designation does not mean the medication is approved or available by prescription.
Breakthrough Therapy Designation is intended to help speed up the development and review of medications that may offer significant improvements over existing treatments for serious conditions. VER-01 must still complete the necessary clinical testing and FDA review before it can be approved as a pharmaceutical medication.
It's important to understand that VER-01 is being developed as a specific pharmaceutical treatment, which is different from state-regulated medical marijuana programs. Ohio has its own medical marijuana program that allows eligible patients to access approved marijuana products through licensed dispensaries, even though those products are not individually FDA-approved.
What Does This Mean for Ohio Medical Marijuana Patients?
Although VER-01 is still being studied, its development highlights the growing interest in understanding how marijuana and individual cannabinoids may help manage medical conditions.
However, VER-01 is different from the marijuana products currently available through Ohio dispensaries. Its clinical trial results should not be used to predict how someone will respond to flower, edibles, vapes, or other products. THC and CBD concentrations, product types, individual tolerance, and medical history can all influence a person's experience. Everyone responds differently, so it's important to understand the potential benefits and risks of different products.
Final Thoughts
The clinical trial of VER-01 is another step toward understanding the potential role of marijuana-based treatments in pain management. Previous European studies have shown promising results, and researchers are now working to determine whether those findings can be replicated in U.S. patients.
Although more research is needed before VER-01 can become an approved treatment, studies like this help expand scientific knowledge about cannabinoids and their potential medical applications.
Get Your Medical Marijuana Card Today!
Having a medical marijuana card in Ohio offers numerous benefits over recreational use. With your medical card, you gain access to higher-quality, lab-tested products, personalized care from knowledgeable physicians, and exclusive dispensary discounts, ensuring you receive safe, effective, and affordable relief. Not to mention, the tax savings are significant when you have your medical card.
Ohio’s medical marijuana program is tailored to prioritize patients’ needs, with evolving qualifying conditions and a commitment to improving access. Whether you’re managing chronic pain, anxiety, or another condition, your medical card empowers you to shop at licensed dispensaries with confidence, knowing you’re receiving products designed specifically for therapeutic use.
Thanks to telemedicine, obtaining your card is simple, quick, and convenient. With an Ohio Marijuana Card, you can complete your evaluation and receive a recommendation on the same day, all from the comfort of home! Schedule your appointment today!
Doctors Who Care
Relief You Can Trust
At Ohio Marijuana Card, we’re here to make the process easy and stress-free. Our team is dedicated to helping you unlock the full benefits of Ohio’s medical marijuana program while improving your overall quality of life.
Don’t wait to start feeling better. Call us at (866) 457-5559 or schedule your evaluation today, and take advantage of the many benefits a medical card has to offer!
For more blogs like this, plus patient resources and state updates, sign up for our newsletter!
Comments